Noninvasive imaging markers in prostate cancer

Endocrine management of breast cancer and advanced breast cancer

Triple negative advanced breast cancer treatment with PARP inhibitors

Analysis of thirty years of clinical trial data

Recent advances in non-Hodgkin’s lymphoma therapy

A new test to determine risk of recurrence in DCIS breast cancer

A test to predict risk of recurrence in DCIS

Everolimus for postmenopausal women with advanced breast cancer

Randomized Phase II Study in Patients with HER2-Positive Breast Cancer

Influence of age and BRCA status on contralateral breast cancer risk

Genetic differences responsible for outcome in hormone receptor positive early stage breast cancer

Bevacizumab improves PFS in HER-2-positive breast cancer